Profile
Darren Snellgrove is identified in SEC filings as the Senior Vice President and Chief Financial Officer of Halozyme Therapeutics, Inc., a publicly traded biopharmaceutical company. As CFO, he is responsible for overseeing Halozyme's finance organization, including accounting, financial planning and analysis, treasury, and investor relations, as reflected in the company’s filings as of the 2026-07-02 reporting period. Specific educational background and prior roles are not provided in the SEC context given.
| Role | SVP, Chief Financial Officer |
|---|---|
| Notability | 55/100 |
Board memberships
- Halozyme Therapeutics, Inc.
Awards & honors
- Oversees Halozyme's finance organization, including accounting, financial planning and analysis, treasury, and investor relations
- Responsible for financial reporting and SEC filings as CFO
- Contributes to capital markets activities and financial strategy in alignment with Halozyme's business objectives